Despite the potential risks, BD concluded from its own assessments that “there is a low probability of harm occurring,” especially because the software is only used to track infusion pump data ...

BD provides advanced IV medication safety solutions, through helping to standardise drug library protocols with the Alaris™ Editor, to protect the patient with Alaris™ Plus Pumps with ...

For BD, bad things seem to come in eights: The medtech giant discovered an octad of potential hacking risks within its Alaris infusion pump systems.

Becton Dickinson (BD) medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the ...

Major players in the ambulatory IV infusion pumps market are Baxter International, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Smith Medical, Terumo Corporation, Fresenius Kabi ...

The technology, known as BD AlarisTM EMR Interoperability, replaces the need for health-care professionals to manually program pumps while sending infusion safety information. Mackenzie Health says ...

An analysis of more than 200,000 infusion pumps, ... which found that IV infusion pumps make up 38% of a hospital's ... in the BD pumps "still had a 50.39% and 39.54% representation in ...